Synonym
MMG-0358; MMG 0358; MMG0358
IUPAC/Chemical Name
4-Chloro-2-(1H-1,2,3-triazol-5-yl)phenol
InChi Key
NBDFMTBYKCBTSW-UHFFFAOYSA-N
InChi Code
InChI=1S/C8H6ClN3O/c9-5-1-2-8(13)6(3-5)7-4-10-12-11-7/h1-4,13H,(H,10,11,12)
SMILES Code
OC1=CC=C(Cl)C=C1C2=CN=NN2
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Biological target:
MMG-0358 is a novel potent IDO1 inhibitor.
|
Solvent |
mg/mL |
mM |
comments |
| Solubility |
| DMF |
20.0 |
102.25 |
|
| DMF:PBS (pH 7.2) (1:4) |
0.2 |
1.02 |
|
| DMSO |
15.0 |
76.68 |
|
| Ethanol |
15.0 |
76.68 |
|
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.
Preparing Stock Solutions
The following data is based on the
product
molecular weight
195.61
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1. Röhrig, U.F., Majjigapu, S.R., Grosdidier, A., et al. Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. J. Med. Chem. 55(11), 5270-5290 (2012).
2. Röhrig, U.F., Reynaud, A., Majjigapu, S.R., et al. Inhibition mechanisms of indoleamine 2,3-dioxygenase 1 (IDO1). J. Med. Chem. 62(19), 8784-8795 (2019).
